source
- Life Biosciences injects experimental cellular reprogramming drug into three glaucoma patients, reports no serious adverse eventsLife Biosciences provided an update on its early‑stage glaucoma study involving its experimental cellular reprogramming therapy. The company said three patients have each received a single intravi…
- Researcher uses Reddit data to map post-Roe abortion access barriersBetsy Pleasants, a postdoctoral researcher at the Center for Women’s Health Research, began studying how the Covid‑19 pandemic affected abortion services while a graduate student at UC Berkeley. W…